In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Osprey Pharmaceutical Co.

Division of CoMentis Inc.

Latest From Osprey Pharmaceutical Co.

Attack of the Killer Bs

2006 has seen an unusual number of large Series B venture rounds in biopharma compared to last year, though Series B rounds haven't been much larger on average.
BioPharmaceutical Strategy

Deals Shaping the Medical Industry (5/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CoMentis Inc.
  • Senior Management
  • Paul Herron, VP and CFO
    Cynthia Brody, VP
  • Contact Info
  • Osprey Pharmaceutical Co.
    Phone: (904) 273-5836
    830-13 A1A North
    Suite 274
    Ponte Vedra Beach, FL 32082